Prediction of novel genes associated with negative regulators of Toll-like receptors-induced inflammation based on endotoxin tolerance

Inflammation

Volumn 35, Issue 6, 2012, Pages 1889-1899

  Yang, Yan ^a   Sun, Hanxiao ^a   Mo, Xuemei ^a   Liu, Yi ^a   Jia, Hongwei ^a   Li, Xiuying ^a   Zhang, Guang ^a   Li, Qin ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Endotoxin tolerance; Gene expression; Inflammation; Negative regulators; Toll like receptor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTOXIN TOLERANCE; GAPDH GENE; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SELECTION; HUMAN; HUMAN CELL; ID2 GENE; ID3 GENE; IMMUNE RESPONSE; INFLAMMATION; MICROARRAY ANALYSIS; MONOCYTE; PAK1 GENE; PREDICTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SGK1 GENE; SMURF 2 GENE; SPRY 2 GENE; TGFBI GENE;

CELLS, CULTURED; ENDOTOXINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-PROTEIN LIGASES;

BACTERIA (MICROORGANISMS);

EID: 84872189977     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9511-0     Document Type: Article

References (47)

1. Nathan, C. 2002. Points of control in inflammation. Nature 420 (6917): 846-852. (Pubitemid 36019637)
2. Xu, X., R.R. Steere, C.A. Fedorchuk, J. Pang, J.Y. Lee, J.H. Lim, H. Xu, Z.K. Pan, S.B. Maggirwar, and J.D. Li. 2011. Activation of epidermal growth factor receptor is required for NTHi-induced NF-κB-dependent inflammation. PLoS One 6 (11): e28216.
3. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annual Review of Immunology 21: 335-376. (Pubitemid 37174535)
4. Triantafilou, K., and M. Triantafilou. 2012. Visualising PAMPPRR interactions using nanoscale imaging. Methods in Molecular Biology 799: 253-266.
5. Gantner, B.N., and H. Singh. 2007. Immunology: short-term memory. Nature 447(7147): 916-917. (Pubitemid 46975740)
6. Homji, N.F., X. Mao, E.F. Langsdorf, and S.L. Chang. 2012. Endotoxin-induced cytokine and chemokine expression in the HIV-1 transgenic rat. Journal of Neuroinflammation 9: 3.
7. Xiang, Q., L. Wen, M.H. Liu, Y. Zhang, J.F. Qu, and J. Tian. 2009. Endotoxin tolerance of RAW264.7 correlates with p38-dependent up-regulation of scavenger receptor-A. The Journal of International Medical Research 37(2): 491-502.
8. Foraker, J.E., J.Y. Oh, J.H. Ylostalo, R.H. Lee, J. Watanabe, and D.J. Prockop. 2011. Cross-talk between human mesenchymal stem/progenitor cells (MSCs) and rat hippocampal slices in LPSstimulated cocultures: the MSCs are activated to secrete prostaglandin E2. Journal of Neurochemistry 119(5): 1052-1063.
9. Choi, E.J., S. Lee, J.R. Chae, H.S. Lee, C.D. Jun, and S.H. Kim. 2011. Eupatilin inhibits lipopolysaccharide-induced expression of inflammatory mediators in macrophages. Life Sciences 88(25-26): 1121-1126.
10. Biswas, S.K., and E. Lopez-Collazo. 2009. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends in Immunology 30(10): 475-487.
11. Piao, W., C. Song, H. Chen, M.A. Diaz, L.M. Wahl, K.A. Fitzgerald, L. Li, and A.E. Medvedev. 2009. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. Journal of Leukocyte Biology 86(4): 863-875.
12. Foster, S.L., D.C. Hargreaves, R. Medzhitov, et al. 2007. Genespecific control of inflammation by TLR-induced chromatin modifications. Nature 447(7147): 972-978. (Pubitemid 46975746)
13. Jorg, Mages, Dietrich Harald, Lang Roland, et al. 2007. A genome-wide analysis of LPS tolerance in macrophages. Immunobiology 212(9-10): 723-737.
14. Chen, J., E.E. Bardes, B.J. Aronow, and A.G. Jegga. 2009. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Research 37(Web Server issue): W305-W311.
15. Rubinstein, R., and I. Simon. 2005. MILANO - custom annotation of microarray results using automatic literature searches. BMC Bioinformatics 6: 12.
16. Chen, H., and B.M. Sharp. 2004. Content-rich biological network constructed bymining PubMed abstracts. BMC Bioinformatics 5: 147.
17. Chen, J., B.J. Aronow, and A.G. Jegga. 2009. Disease candidate gene identification and prioritization using protein interaction networks. BMC Bioinformatics 10: 73.
18. Aerts, S., D. Lambrechts, S. Maity, P. Van Loo, B. Coessens, F. De Smet, L.C. Tranchevent, B. De Moor, P. Marynen, B. Hassan, P. Carmeliet, and Y. Moreau. 2006. Gene prioritization through genomic data fusion. Nature Biotechnology 24(5): 537-544.
19. del Fresno, C., F. García-Rio, V. Gómez-Piña, A. Soares-Schanoski, I. Fernández-Ruíz, T. Jurado, T. Kajiji, C. Shu, E. Marín, A. del Arroyo Gutierrez, C. Prados, F. Arnalich, P. Fuentes-Prior, S.K. Biswas, and E. López-Collazo. 2009. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide- tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. Journal of Immunology 182(10): 6494-6507.
20. Chen, J., H. Xu, B.J. Aronow, and A.G. Jegga. 2007. Improved human disease candidate gene prioritization using mouse phenotype. BMC Bioinformatics 8: 392.
21. Vollmar, B. 2011. Pathophysiological basis of surgery-linked sepsis. Chirurg 82(3): 199-207.
22. Kim, G., J.B. Jun, and K.B. Elkon. 2002. Necessary role of phosphatidylinositol 3-kinase in transforming growth factor betamediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism 46(6): 1504-1511. (Pubitemid 34620196)
23. Wahl, S.M., and W. Chen. 2005. Transforming growth factor-betainduced regulatory T cells referee inflammatory and autoimmune diseases. Arthritis Research & Therapy 7(2): 62-68. (Pubitemid 40439440)
24. Xu, J., and Y. Li. 2006. Discovering disease-genes by topological features in human protein-protein interaction network. Bioinformatics 22(22): 2800-2805. (Pubitemid 44742401)
25. Ortutay, C., and M. Vihinen. 2009. Identification of candidate disease genes by integrating Gene Ontologies and protein-interaction networks: case study of primary immunodeficiencies. Nucleic Acids Research 37(2): 622-628.
26. Piersa, J., F. Piekniewski, and T. Schreiber. 2010. Theoretical model for mesoscopic-level scale-free self-organization of functional brain networks. IEEE Transactions on Neural Networks 21(11): 1747-1758.
27. Minor, E.S., and D.L. Urban. 2008. A graph-theory framework for evaluating landscape connectivity and conservation planning. Conservation Biology 22(2): 297-307. (Pubitemid 351503417)
28. Sharan, R., and T. Ideker. 2006. Modeling cellular machinery through biological network comparison. Nature Biotechnology 24 (4): 427-433.
29. Nabieva, E., K. Jim, A. Agarwal, B. Chazelle, and M. Singh. 2005. Whole-proteome prediction of protein function via graph-theoretic analysis of interaction maps. Bioinformatics 21(Suppl 1): i302-310. (Pubitemid 41794502)
30. Sam L, Liu Y, Li J, Friedman C, Lussier YA. 2007. Discovery of protein interaction networks shared by diseases. Pac Symp Biocomput 76-87.
31. Goehler, H., M. Lalowski, U. Stelzl, S. Waelter, M. Stroedicke, U. Worm, A. Droege, K.S. Lindenberg, M. Knoblich, C. Haenig, M. Herbst, J. Suopanki, E. Scherzinger, C. Abraham, B. Bauer, R. Hasenbank, A. Fritzsche, A.H. Ludewig, K. Büssow, S.H. Coleman, C.A. Gutekunst, B.G. Landwehrmeyer, H. Lehrach, and E.E. Wanker. 2004. A protein interaction network links GITI, an enhancer of huntingtin aggregation, to Huntington's disease. Molecular Cell 15(6): 853-865. (Pubitemid 39277983)
32. Oti, M., B. Snel, M.A. Huynen, and H.G. Brunner. 2006. Predicting disease genes using protein-protein interactions. Journal of Medical Genetics 43(8): 691-698. (Pubitemid 44214908)
33. Karni, S., H. Soreq, and R. Sharan. 2009. A network-based method for predicting disease-causing genes. Journal of Computational Biology 16(2): 181-189.
34. Sharan, R., I. Ulitsky, and R. Shamir. 2007. Network-based prediction of protein function. Molecular Systems Biology 3: 88.
35. Goh, K.I., M.E. Cusick, D. Valle, B. Childs, M. Vidal, and A.L. Barabási. 2007. The human disease network. Proceedings of the National Academy of Sciences of the United States of America 104 (21): 8685-8590.
36. Li, D., J. Li, S. Ouyang, J. Wang, S. Wu, P. Wan, Y. Zhu, X. Xu, and F. He. 2006. Protein interaction networks of Saccharomyces cerevisiae, Caenorhabditis elegans and Drosophila melanogaster: large-scale organization and robustness. Proteomics 6(2): 456-461. (Pubitemid 43208025)
37. Pujana, M.A., J.D. Han, L.M. Starita, K.N. Stevens, M. Tewari, J.S. Ahn, G. Rennert, V. Moreno, T. Kirchhoff, B. Gold, V. Assmann, W.M. Elshamy, J.F. Rual, D. Levine, L.S. Rozek, R.S. Gelman, K.C. Gunsalus, R.A. Greenberg, B. Sobhian, N. Bertin, K. Venkatesan, N. Ayivi-Guedehoussou, X. Solé, P. Hernández, C. Lázaro, K.L. Nathanson, B.L. Weber, M.E. Cusick, D.E. Hill, K. Offit, D.M. Livingston, S.B. Gruber, J.D. Parvin, and M. Vidal. 2007. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature Genetics 39(11): 1338-1349. (Pubitemid 350035000)
38. Wong, E.S., C.W. Fong, J. Lim, P. Yusoff, B.C. Low, W.Y. Langdon, and G.R. Guy. 2002. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling. EMBO Journal 21(18): 4796-4808.
39. Guy, G.R., R.A. Jackson, P. Yusoff, and S.Y. Chow. 2009. Sprouty proteins: modified modulators, matchmakers or missing links? Journal of Endocrinology 203(2): 191-202.
40. Yusoff, P., D.H. Lao, S.H. Ong, E.S. Wong, J. Lim, T.L. Lo, H.F. Leong, C.W. Fong, and G.R. Guy. 2002. Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. Journal of Biological Chemistry 277(5): 3195-3201. (Pubitemid 34953181)
41. Lo, T.L., C.W. Fong, P. Yusoff, A.B. McKie, M.S. Chua, H.Y. Leung, and G.R. Guy. 2006. Sprouty and cancer: the first terms report. Cancer Letters 242(2): 141-150. (Pubitemid 44515046)
42. Fong, C.W., M.S. Chua, A.B. McKie, S.H. Ling, V. Mason, R. Li, P. Yusoff, T.L. Lo, H.Y. Leung, S.K. So, and G.R. Guy. 2006. Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Research 66(4): 2048-2058.
43. Grassian, A.R., Z.T. Schafer, and J.S. Brugge. 2011. ErbB2 stabilizes epidermal growth factor receptor (EGFR) expression via Erk and Sprouty2 in extracellular matrix-detached cells. Journal of Biological Chemistry 286(1): 79-90.
44. Frank, M.J., D.W. Dawson, S.J. Bensinger, J.S. Hong, W.M. Knosp, L. Xu, C.E. Balatoni, E.L. Allen, R.R. Shen, D. Bar-Sagi, G.R. Martin, M.A. Teitell, et al. 2009. Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas. Blood 113(11): 2478-2487.
45. Blank, M., Y. Tang, M. Yamashita, S.S. Burkett, S.Y. Cheng, and Y.E. Zhang. 2012. A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20. Nature Medicine 18(2): 227-234.
46. Ray, D., A. Ahsan, A. Helman, G. Chen, A. Hegde, S.R. Gurjar, L. Zhao, H. Kiyokawa, D.G. Beer, T.S. Lawrence, and M.K. Nyati. 2011. Regulation of EGFR protein stability by the HECT-type ubiquitin ligase SMURF2. Neoplasia 13(7): 570-578.
47. Pellegrini, M., T. Calzascia, A.R. Elford, A. Shahinian, A.E. Lin, D. Dissanayake, S. Dhanji, L.T. Nguyen, M.A. Gronski, M. Morre, B. Assouline, K. Lahl, T. Sparwasser, P.S. Ohashi, and T.W. Mak. 2009. Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies. Nature Medicine 15(5): 528-536.